| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 |
| filingDate |
1998-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_037d08df0a831ecf0c9414547480d686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b3e7b53784c03f6edcd11cf540b4da5 |
| publicationDate |
1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9927921-A2 |
| titleOfInvention |
Compositions and methods for modulating the activity of fibroblast growth factor |
| abstract |
Methods for using bis-sulfonamide compounds of formula (I) and pharmaceutical compositions containing the compounds of formula (I) or pharmaceutically acceptable derivatives thereof for modulating the activity of the FGF family of peptides are provided. Methods for inhibiting the binding of an FGF peptide to an FGF receptor by contacting the receptor with a bis-sulfonamide compound of formula (I) are provided. Methods for treating FGF-mediated disorders by administering effective amounts of one or more of these bis-sulfonamides or prodrugs thereof that inhibit the activity of one or more FGF peptide are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1643958-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1643958-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7396859-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7510825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074346-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074346-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0030632-A1 |
| priorityDate |
1997-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |